📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Hyperion Therapeutics

1.1 - Company Overview

Hyperion Therapeutics Logo

Hyperion Therapeutics

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biopharmaceutical therapies focused on treating urea cycle disorders and other rare diseases for orphan or underserved patient populations; based in South San Francisco, CA.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Hyperion Therapeutics

Travere Therapeutics Logo

Travere Therapeutics

HQ: United States Website
  • Description: Provider of drug discovery and development for catastrophic, debilitating and often life-threatening diseases, including a non-immunosuppressive medication developed for the treatment of IgA nephropathy, a rare kidney disorder.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Travere Therapeutics company profile →
Alseres Logo

Alseres

HQ: United States Website
  • Description: Provider of diagnostic and therapeutic product development focused on disorders in the central.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Alseres company profile →
Phathom Pharmaceuticals Logo

Phathom Pharmaceuticals

HQ: United States Website
  • Description: Provider of biopharmaceutical development focused on vonoprazan, a potassium-competitive acid blocker under clinical study for acid-related gastrointestinal disorders, including GERD and H. pylori. Activities include the pHalcon-NERD Phase 2 on-demand and Phase 3 daily dosing trials for NERD, and an Expanded Access Policy (no products currently available through this program).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Phathom Pharmaceuticals company profile →
Xinvento Logo

Xinvento

HQ: The Netherlands Website
  • Description: Provider of a credible alternative treatment for congenital hyperinsulinism.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Xinvento company profile →
Censa Pharmaceuticals Logo

Censa Pharmaceuticals

HQ: United States Website
  • Description: Provider of therapeutics for (ultra) orphan CNS disorders, primarily focused on their development and commercialization.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Censa Pharmaceuticals company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Hyperion Therapeutics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Hyperion Therapeutics

2.2 - Growth funds investing in similar companies to Hyperion Therapeutics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Hyperion Therapeutics

4.2 - Public trading comparable groups for Hyperion Therapeutics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Hyperion Therapeutics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Hyperion Therapeutics

What does Hyperion Therapeutics do?

Hyperion Therapeutics is a provider of biopharmaceutical therapies focused on treating urea cycle disorders and other rare diseases for orphan or underserved patient populations; based in South San Francisco, CA.

Who are Hyperion Therapeutics's competitors?

Hyperion Therapeutics's competitors and similar companies include Travere Therapeutics, Alseres, Phathom Pharmaceuticals, Xinvento, and Censa Pharmaceuticals.

Where is Hyperion Therapeutics headquartered?

Hyperion Therapeutics is headquartered in United States.

How many employees does Hyperion Therapeutics have?

Hyperion Therapeutics has 1,000 employees 🔒.

When was Hyperion Therapeutics founded?

Hyperion Therapeutics was founded in 2010 🔒.

What sector and industry vertical is Hyperion Therapeutics in?

Hyperion Therapeutics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Hyperion Therapeutics

Who are the top strategic acquirers in Hyperion Therapeutics's sector and industry

Top strategic M&A buyers and acquirers in Hyperion Therapeutics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Hyperion Therapeutics?

Top strategic M&A buyers groups and sectors for Hyperion Therapeutics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Hyperion Therapeutics's sector and industry vertical

Which are the top PE firms investing in Hyperion Therapeutics's sector and industry vertical?

Top PE firms investing in Hyperion Therapeutics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Hyperion Therapeutics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Hyperion Therapeutics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Hyperion Therapeutics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Hyperion Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Hyperion Therapeutics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Hyperion Therapeutics?

The key public trading comparables and valuation benchmarks for Hyperion Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Hyperion Therapeutics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Hyperion Therapeutics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Hyperion Therapeutics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Hyperion Therapeutics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Hyperion Therapeutics's' sector and industry vertical?

Access recent funding rounds and capital raises in Hyperion Therapeutics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Hyperion Therapeutics